Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials

INTRODUCTION: Hydroxycloroquine (HCQ) has been extensively studied for treatment and prevention of coronavirus diseases 2019 (COVID‐19) from the start of the pandemic. Conflicting evidence about its usefulness has begun to accrue. METHODS: In the face of controversial results about clinical efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraolo, Alberto Enrico, Grossi, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753686/
https://www.ncbi.nlm.nih.gov/pubmed/33244901
http://dx.doi.org/10.1002/iid3.374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753686/
https://www.ncbi.nlm.nih.gov/pubmed/33244901
http://dx.doi.org/10.1002/iid3.374

Ejemplares similares